Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Senior Global Program Safety Lead Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 04, 2024
T&L Operational Expert Hyderabad (Office) India Operations Innovative Medicines Human Resources Oct 04, 2024
Assoc. Dir. DDIT US&I Service Management Access Hyderabad (Office) India Operations CTS Technology Transformation Oct 04, 2024
Associate Director, Forecasting & Capacity Planning Arizona USA US Innovative Medicines Sales Oct 04, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
Project Manager DD&IT M&A US&I INSURGENTES Mexico Operations CTS Technology Transformation Oct 04, 2024
Cardiovascular Territory Account Specialist (Part-Time) – Bakersfield, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 04, 2024
Allergy- Territory Account Specialist – Riverside, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Associate Director, Curriculum Design East Hanover USA US Innovative Medicines Sales Oct 04, 2024
Data Scientist/Computational Chemist (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Data and Digital Oct 04, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
RWE Lead H/F CDD 12 mois Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Research & Development Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Sales Value Associate - MTY Público INSURGENTES Mexico International Innovative Medicines Sales Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Consultor Técnico Especialidades Sênior Santo Amaro Brazil International Innovative Medicines Sales Oct 04, 2024
Senior W&D Analyst Santo Amaro Brazil Operations Innovative Medicines Technical Operations Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Specialist-Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 03, 2024
Senior Principal Biostatistician Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 03, 2024
Višji skrbnik osnovnih podatkov materialov (m/ž/d) / Senior Site Master Data Expert (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 03, 2024
Specialist Representative- Cardiovascular Bangkok Thailand International Innovative Medicines Sales Oct 03, 2024
Study Start Up Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 03, 2024
Global Program Regulatory Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 03, 2024
Manager - Strategy and Operations Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 03, 2024
Senior Global Program Regulatory Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 03, 2024
Ekspert tehnologije izdelkov III / Product Steward III Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 03, 2024
Global Strategic Partnerships Lead, ASCEND Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 03, 2024
Global Category Manager MRO Warsaw Poland Operations Innovative Medicines Procurement Oct 03, 2024
Sr. Spec. DDIT IES Workforce Mgmt. Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
HR People Partner - Italy Ivrea Italy International Innovative Medicines Human Resources Oct 03, 2024
Assistant Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 03, 2024
Compliance Regulatory Affairs Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 03, 2024
Manager, Evidence Generation Hyderabad (Office) India Operations CTS Market Access Oct 03, 2024
Clinical Research Medical Advisor Metamorfosis Greece Development Innovative Medicines Research & Development Oct 03, 2024
Head Enterprise & Innovation Solutions, PTDI Hyderabad (Office) India People & Organization CTS Human Resources Oct 03, 2024
Lead, Capability Learning Solutions Hyderabad (Office) India Development Innovative Medicines Human Resources Oct 03, 2024
Spec. DDIT IES CIS Security Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
Associate Director DDIT ISC CSOC Engineering Prague Czech Republic Operations CTS Technology Transformation Oct 03, 2024
Logistics Coordinator (Import) East Hanover USA Operations Innovative Medicines Technical Operations Oct 03, 2024
Functional Architect (Salesforce/ Patient Services) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia